FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997988932> ?p ?o ?g. }

• W1997988932 endingPage "56" @default.
• W1997988932 startingPage "49" @default.
• W1997988932 abstract "BACKGROUND. Immunohistochemistry is helpful in distinguishing metastatic carcinoma from atypical mesothelial cells; however, it is not useful in differentiating atypical mesothelial cells from malignant mesothelial cells. K homolog domain containing protein overexpressed in cancer (KOC), a member of the insulin-like growth factor mRNA-binding protein (IMP) family, also known as L523S and IMP3, is expressed during embryogenesis and in various malignancies. Using a mouse monoclonal antibody (L523S) against KOC, KOC expression was investigated in malignant tumors and reactive mesothelial cells in serous effusions. METHODS. Seventy-six cases with paraffin-embedded pleural, pericardial, and peritoneal serous effusion cell blocks including 60 malignant serous effusions (11 malignant pleural mesotheliomas and 49 metastatic carcinomas) and benign pleural effusions (14 cases with reactive mesothelial cells and 2 cases with atypical cells with uncertain significance) were selected for immunohistochemical analysis with L523S, calretinin, and CK5/6. RESULTS. Immunohistochemical studies showed that positive staining for KOC of variable degrees of intensity was observed in 47 of 60 cases in malignant serous effusions including 10 of 11 mesotheliomas and 36 of 49 metastatic carcinomas. The associated reactive mesothelial cells were negative for KOC but positive for calretinin and CK5/6. All 11 malignant mesotheliomas exhibited positivity for calretinin, and 9 of 11 cases had CK5/6 staining. In addition, 16 cases that were originally diagnosed either as pleural effusions with reactive mesothelial cells (14) or atypical cells with uncertain significance (2) were also tested for KOC expression. Interestingly, 3 of 16 cases exhibited various degrees of positivity for KOC, 2 of which were diagnosed as lung adenocarcinoma with a recurrence after tumor resection and 1 as malignant pleural mesothelioma. CONCLUSIONS. Anti-L523S antibody is a useful marker for the detection of malignant cells in serous effusions and it can have significant utility in differentiating reactive mesothelial cells from malignant mesothelioma and metastatic carcinoma in combination with calretinin and CK5/6 staining. Cancer (Cancer Cytopathol) 2008. © 2007 American Cancer Society." @default.
• W1997988932 created "2016-06-24" @default.
• W1997988932 creator A5008581924 @default.
• W1997988932 creator A5009458650 @default.
• W1997988932 creator A5020795931 @default.
• W1997988932 creator A5038852703 @default.
• W1997988932 creator A5069279971 @default.
• W1997988932 creator A5078848465 @default.
• W1997988932 creator A5090428050 @default.
• W1997988932 date "2007-12-20" @default.
• W1997988932 modified "2023-10-12" @default.
• W1997988932 title "Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions" @default.
• W1997988932 cites W1990721572 @default.
• W1997988932 cites W1996237444 @default.
• W1997988932 cites W1997793644 @default.
• W1997988932 cites W2002158796 @default.
• W1997988932 cites W2031125959 @default.
• W1997988932 cites W2033249060 @default.
• W1997988932 cites W2034042682 @default.
• W1997988932 cites W2051685994 @default.
• W1997988932 cites W2052231641 @default.
• W1997988932 cites W2053613923 @default.
• W1997988932 cites W2054020417 @default.
• W1997988932 cites W2058427048 @default.
• W1997988932 cites W2073482890 @default.
• W1997988932 cites W2076693259 @default.
• W1997988932 cites W2079437125 @default.
• W1997988932 cites W2083253529 @default.
• W1997988932 cites W2105830380 @default.
• W1997988932 cites W2117524191 @default.
• W1997988932 cites W2117720293 @default.
• W1997988932 cites W2141155061 @default.
• W1997988932 cites W2160413016 @default.
• W1997988932 cites W2164065167 @default.
• W1997988932 cites W2185082678 @default.
• W1997988932 doi "https://doi.org/10.1002/cncr.23254" @default.
• W1997988932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18098206" @default.
• W1997988932 hasPublicationYear "2007" @default.
• W1997988932 type Work @default.
• W1997988932 sameAs 1997988932 @default.
• W1997988932 citedByCount "38" @default.
• W1997988932 countsByYear W19979889322012 @default.
• W1997988932 countsByYear W19979889322013 @default.
• W1997988932 countsByYear W19979889322014 @default.
• W1997988932 countsByYear W19979889322015 @default.
• W1997988932 countsByYear W19979889322017 @default.
• W1997988932 countsByYear W19979889322018 @default.
• W1997988932 countsByYear W19979889322019 @default.
• W1997988932 countsByYear W19979889322020 @default.
• W1997988932 countsByYear W19979889322021 @default.
• W1997988932 countsByYear W19979889322023 @default.
• W1997988932 crossrefType "journal-article" @default.
• W1997988932 hasAuthorship W1997988932A5008581924 @default.
• W1997988932 hasAuthorship W1997988932A5009458650 @default.
• W1997988932 hasAuthorship W1997988932A5020795931 @default.
• W1997988932 hasAuthorship W1997988932A5038852703 @default.
• W1997988932 hasAuthorship W1997988932A5069279971 @default.
• W1997988932 hasAuthorship W1997988932A5078848465 @default.
• W1997988932 hasAuthorship W1997988932A5090428050 @default.
• W1997988932 hasBestOaLocation W19979889321 @default.
• W1997988932 hasConcept C121608353 @default.
• W1997988932 hasConcept C126322002 @default.
• W1997988932 hasConcept C142724271 @default.
• W1997988932 hasConcept C150173356 @default.
• W1997988932 hasConcept C204232928 @default.
• W1997988932 hasConcept C2777407522 @default.
• W1997988932 hasConcept C2777632260 @default.
• W1997988932 hasConcept C2779634585 @default.
• W1997988932 hasConcept C2779747549 @default.
• W1997988932 hasConcept C2780427987 @default.
• W1997988932 hasConcept C2781404787 @default.
• W1997988932 hasConcept C2909640154 @default.
• W1997988932 hasConcept C502942594 @default.
• W1997988932 hasConcept C71924100 @default.
• W1997988932 hasConcept C74864618 @default.
• W1997988932 hasConceptScore W1997988932C121608353 @default.
• W1997988932 hasConceptScore W1997988932C126322002 @default.
• W1997988932 hasConceptScore W1997988932C142724271 @default.
• W1997988932 hasConceptScore W1997988932C150173356 @default.
• W1997988932 hasConceptScore W1997988932C204232928 @default.
• W1997988932 hasConceptScore W1997988932C2777407522 @default.
• W1997988932 hasConceptScore W1997988932C2777632260 @default.
• W1997988932 hasConceptScore W1997988932C2779634585 @default.
• W1997988932 hasConceptScore W1997988932C2779747549 @default.
• W1997988932 hasConceptScore W1997988932C2780427987 @default.
• W1997988932 hasConceptScore W1997988932C2781404787 @default.
• W1997988932 hasConceptScore W1997988932C2909640154 @default.
• W1997988932 hasConceptScore W1997988932C502942594 @default.
• W1997988932 hasConceptScore W1997988932C71924100 @default.
• W1997988932 hasConceptScore W1997988932C74864618 @default.
• W1997988932 hasIssue "1" @default.
• W1997988932 hasLocation W19979889321 @default.
• W1997988932 hasLocation W19979889322 @default.
• W1997988932 hasOpenAccess W1997988932 @default.
• W1997988932 hasPrimaryLocation W19979889321 @default.
• W1997988932 hasRelatedWork W2041683934 @default.
• W1997988932 hasRelatedWork W2066660928 @default.
• W1997988932 hasRelatedWork W2181855412 @default.

• next